What You Should Know:
Today, Verily and L’Oreal announced the launch of a multi-year study, My Skin & Hair Journey, to advance precision skin and hair health. This is part of the two companies' multi-year partnership and research collaboration. The My Skin & Hair Journey registry will enroll thousands of self-identifying U.S. women to develop an unprecedented body of knowledge about perceptions and experiences of skin and hair health, including the role of lifestyle,
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Volume and Cost of Clinical Lab Tests Expected to Rise in 2023
What You Should Know:
According to a new report on lab trends, the overall number of routine lab tests declined from 2021 to 2022, largely due to a reduction in COVID-19 tests. However, the number of non-COVID tests rose during the same period and is expected to continue to grow, along with overall spending on tests.The 2023 Lab Trend Report comes from Avalon Healthcare Solutions, a Lab Insights company that provides an annual evaluation of the status of U.S. clinical lab testing and an
Read More
Abbott Receives FDA Approval for World’s First Dual Chamber Leadless Pacemaker
What You Should Know:
The U.S. Food and Drug Administration (FDA) approves Abbott’s AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms.Abbott’s breakthrough technology enables the world's first beat-to-beat, wireless communication and synchronization between two leadless pacemakers, which are smaller than a AAA batteryLeadless pacemakers provide a new minimally invasive option
Read More
How to Achieve Health Equity in Decentralized Clinical Trials
Trial sponsors have made efforts to address underrepresentation and promote Diversity, Equity and Inclusion (DEI) in clinical trials since the Federal and Drug Administration’s (FDA) 2016 guidance, but a new report released by the Government Accountability Office (GAO) still shows a continuous presence of major gaps in patient diversity. It begs the question: how do we ultimately achieve full representation and ensure accountability to uphold the promises we have made for
Read More
Flywheel Secures $54M for Medical AI Imaging Platform
What You Should Know:
Flywheel, a Minneapolis-based medical imaging data and AI platform raises $54M in Series D funding, backed by tech giants including NVIDIA, Microsoft, and more.Flywheel helps organizations turn complex imaging data into analysis-ready datasets for accelerated research and AI development. Flywheel offers comprehensive solutions for pharma companies, providers, payers, system integrators, AI developers and academic medical centers to get optimum value out of
Read More
Why Interoperability is Key to Successful Digital Pharma Solutions
We are at an interesting crossroads when it comes to pharma and digital health. Several years after the first iteration of digital patient solutions was initially launched, many pharma companies are taking a step back to strategically evaluate how they have performed in practice and the impact they have had on both patient and business outcomes.
Unfortunately, many platforms that pharma companies have either integrated within existing platforms or built have failed to meet those needs – for
Read More
Abbott, American Diabetes Association Launches Therapeutic Nutrition Program for People with Diabetes
What You Should Know:
American Diabetes Association® (ADA) and Abbott announced a collaboration a new collaboration on a pilot therapeutic nutrition program to help people living with Type 2 diabetes.The collaboration aims to understand how diabetes technology like continuous glucose monitoring (CGM) systems can help people living with diabetes make informed decisions about their food and activity.
Abbott’s $2.6M Grant to Support Diabetes
Abbott is providing a $2.65 million grant
Read More
Oaktree Closes $2.3B Life Sciences Lending Fund
What You Should Know:
Oaktree Capital Management has closed its Life Sciences Lending Fund with a total capital commitment of $2.3B, representing the largest pool of capital ever raised dedicated to the space. Oaktree’s Life Sciences Lending Fund aims to generate attractive risk-adjusted returns by providing bespoke capital solutions to innovative companies across the life sciences sector globally, with a focus on high-growth subsectors, such as biopharma and medical
Read More
AWS Launches $100M Generative AI Center to Accelerate Healthcare, Life Sciences
What You Should Know:
Amazon Web Services, Inc. (AWS) announced an investment of $100M to launch the AWS Generative AI Innovation Center, with healthcare and life sciences as a prioritized industry (alongside Financial Services, Energy & Utilities, Telco, and others). The AWS Generative AI Innovation Center will connect AWS AI and machine learning (ML) experts with customers around the globe to help them envision, design, and launch new generative AI products, services, and
Read More
Feasibility of Cryoablation as a Treatment for Invasive Ductal Carcinoma
Millions of women worldwide are affected by breast cancer, a prevalent form of cancer. For approximately 8 out of 10 cases, invasive ductal carcinoma (IDC) is the most prevalent form of breast cancer. IDC is characterized by cancer cells that have spread beyond the milk ducts into the surrounding breast tissue.
While surgery, chemotherapy, and radiation therapy are commonly used to treat IDC, there is growing interest in alternative treatment options such as cryoablation provided by the ICE3
Read More
